Health Discovery, DCL Ink Cancer Dx Collaboration | GenomeWeb
NEW YORK (GenomeWeb News) – Health Discovery Corporation has partnered with DCL Medical Laboratories to develop and commercialize DCL’s diagnostic tests for ovarian, cervical, and endometrial cancers.
 
Under the agreement, Savannah, Ga.-based HDC will own the developed intellectual property and DCL will have a sole-use license for applications and new mathematical tools that are developed over the course of the collaboration.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.